首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Study on bone marrow angiogenic mediators and inhibitors in aplastic anemia
Authors:ZHOU Zhen-hai  LI Xiao-yin  LI Juan  LUO Shao-kai  CHEN Yun-xian
Institution:Department of Hematology,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510080,China.E-mail:zzhallen@tom.com
Abstract:AIM: Through detecting bone marrow angiogenic mediators and inhibitors in aplastic anemia (AA) patients,the value of angionesis in AA pathogenesis was elucidated.METHODS: The patients were divided into severe AA group (SAA,8 patients),non severe AA group (NSAA,10 patients),and normal control group (7 persons),5 patients were observed before treating (group beginning) and getting improvement (group improving).The angiogenic mediators vascular endothelial growth factor (VEGF) and bFGF were detected by ELISA,angiogenic inhibitors IFN-γ and TSP were detected by ELISA and flow cytometry,respectively.RESULTS: The levels of VEGF were lower in SAA group and NSAA group than those in control group significantly (P<0.05),the levels of IFN-γ and TSP were higher than those in control group (P<0.05),especially in SAA group (P<0.01).Compared with group beginning,the level of VEGF was higher in group improving (P<0.05),the levels of IFN-γ,TSP were lower (P<0.05),there was no obviously difference between group beginning and group improving except IFN-γ.CONCLUSION: The dropping of angiogenic mediators and the rising of angiogenic inhibitors may be one reason of reducing the number of microvessel,which result in deficiency in supporting hemapoietic stem cells by bone marrow microenvironment.
Keywords:Anemia  aplastic  Angiogenesis factor  Angiogenesis inhibitors  
点击此处可从《园艺学报》浏览原始摘要信息
点击此处可从《园艺学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号